Notes:

Latest blog posts from Patent Baristas

Upcoming Patent Events: Pharma/Biotech IP Due Diligence
Whether you are a company conducting diligence or a target being examined, you need to ensure the value of the IP with a thorough and effective IP due diligence review. In this light, the American Conference Institute’s 6th National Conference on Pharma/Biotech IP Due Diligence will be held at... Read more...
Published 5 hours ago

So, How (and When) Will You Get Your Patent Term Adjustment Corrected?
As we saw in the Wyeth v. Dudas case, the US District Court for the District of Columbia overturned the USPTO’s interpretation of 35 USC § 154 (the statute that prescribes patent terms). Section 154 grants extensions of patent terms for certain kinds of PTO delay.  However, Congress says you... Read more...
Published 6 days ago

Down a Rabbit Hole: Court Slaps Down Patent Office’s ‘Explanation’ of PTA Rules
On September 30, 2008, the US District Court for the District of Columbia overturned the interpretation of 35 USC § 154 (the statute that prescribes patent terms) by the United States Patent and Trademark Office (PTO).  See Wyeth v. Dudas, No. 07-1492 (D.D.C. September 30, 2008). Section... Read more...
Published 6 days ago

Pharmaceutical Patent Law: A Prescription for Success in Challenging Times
BNA, the leading provider of expert information and analysis, presents a one-day, information-packed conference entitled Pharmaceutical Patent Law: A Prescription for Success in Challenging Times. The conference will be held at the Ritz-Carlton, Pentagon City, 1250 South Hayes Street, Arlington,... Read more...
Published a week ago

Unhappy with the Ex parte Appeal Rule? Speak Now.
Today the PTO published a notice in the Federal Register inviting public comments on paperwork burdens associated with the Ex parte Appeal Rule (73 Fed. Reg. 32937-32977, June 10, 2008).  This Information Collection Request (ICR)  an application from an agency to OMB for OMB’s approval... Read more...
Published a week ago